NCT01850277 Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study Status UNKNOWN Phase PHASE4
NCT01841944 Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction Status COMPLETED Phase NA
NCT01839357 Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left Atrial/Left Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter Status COMPLETED Phase PHASE3
NCT01830543 A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention Status COMPLETED Phase PHASE3
NCT01824394 nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation Status TERMINATED Phase PHASE3
NCT01818583 Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter Status COMPLETED Phase PHASE4
NCT01817439 Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF Status UNKNOWN Phase PHASE3
NCT01814111 Renal Sympathetic Denervation in Patients With Hypertension and Paroxysmal Atrial Fibrillation Status UNKNOWN Phase NA
NCT01812356 The Concomitant Cryomaze Procedure Using Nitreous Oxide Cryoprobe: Comparison With Argon Based Cryoprobe Status COMPLETED Phase NA
NCT01809015 Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme Status COMPLETED Phase N/A
NCT01805960 Canakinumab for the Prevention of Recurrences After Electrical Cardioversion: CONVERT-AF Status TERMINATED Phase PHASE2